Serveur d'exploration sur le LRGP

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
***** Acces problem to record *****\

Identifieur interne : 000000 ( Pmc/Corpus ); suivant : 0000010 ***** probable Xml problem with record *****

Links to Exploration step


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy</title>
<author>
<name sortKey="Allal, A S" sort="Allal, A S" uniqKey="Allal A" first="A S" last="Allal">A S Allal</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Division of Radiation Oncology</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Sprangers, M A G" sort="Sprangers, M A G" uniqKey="Sprangers M" first="M A G" last="Sprangers">M A G. Sprangers</name>
<affiliation>
<nlm:aff id="aff3">Department of Medical Psychology, Academic Medical Center, 1105 Amsterdam, The Netherlands</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Laurencet, F" sort="Laurencet, F" uniqKey="Laurencet F" first="F" last="Laurencet">F. Laurencet</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Division of Radiation Oncology</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Reymond, M A" sort="Reymond, M A" uniqKey="Reymond M" first="M A" last="Reymond">M A Reymond</name>
<affiliation>
<nlm:aff id="aff1">Department of Surgery, University Hospital of Geneva, 1211 Geneva 14, Switzerland</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kurtz, J M" sort="Kurtz, J M" uniqKey="Kurtz J" first="J M" last="Kurtz">J M Kurtz</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Division of Radiation Oncology</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">10408404</idno>
<idno type="pmc">2363100</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363100</idno>
<idno type="RBID">PMC:2363100</idno>
<idno type="doi">10.1038/sj.bjc.6690567</idno>
<date when="1999">1999</date>
<idno type="wicri:Area/Pmc/Corpus">000000</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000000</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy</title>
<author>
<name sortKey="Allal, A S" sort="Allal, A S" uniqKey="Allal A" first="A S" last="Allal">A S Allal</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Division of Radiation Oncology</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Sprangers, M A G" sort="Sprangers, M A G" uniqKey="Sprangers M" first="M A G" last="Sprangers">M A G. Sprangers</name>
<affiliation>
<nlm:aff id="aff3">Department of Medical Psychology, Academic Medical Center, 1105 Amsterdam, The Netherlands</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Laurencet, F" sort="Laurencet, F" uniqKey="Laurencet F" first="F" last="Laurencet">F. Laurencet</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Division of Radiation Oncology</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Reymond, M A" sort="Reymond, M A" uniqKey="Reymond M" first="M A" last="Reymond">M A Reymond</name>
<affiliation>
<nlm:aff id="aff1">Department of Surgery, University Hospital of Geneva, 1211 Geneva 14, Switzerland</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kurtz, J M" sort="Kurtz, J M" uniqKey="Kurtz J" first="J M" last="Kurtz">J M Kurtz</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Division of Radiation Oncology</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">British Journal of Cancer</title>
<idno type="ISSN">0007-0920</idno>
<idno type="eISSN">1532-1827</idno>
<imprint>
<date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>This study was conducted to assess long-term Quality of Life (QOL) in patients treated by radiotherapy with or without chemotherapy for anal carcinomas. Patients with a maximum age of 80 years, and who were alive at least 3 years following completion of treatment with a functioning anal sphincter and without active disease, were selected for this study. Of 52 such patients identified, 41 (79%) were evaluable. There were 35 females and six males with a median age of 71 years (55–80). The median follow-up interval was 116 months (range 37–218). QOL was assessed using two self-rating questionnaires developed by the European Organization for Research and Treatment of Cancer: one for cancer-specific QOL (EORTC QLQ-C30) and one for site-specific QOL (EORTC QLQ-CR38). For the function scales a higher score represents a higher level of functioning (100 being the best score), whereas for the symptom scales a higher score indicates a higher level of symptomatology/problems (0 being the best score). For the QLQ-C30, the functional scale scores ranged from 71 (global quality of life) to 85 (role function) and the symptom scale scores from 6 (nausea-vomiting) to 28 (diarrhoea). For the QLQ-CR38 module the functional scale scores ranged from 13 (sexual functioning) to 74 (body image) and for the symptom scale scores from 5 (weight loss) to 66 (sexual dysfunction in males). None of the functional and symptom scale scores seemed to be better in patients with longer follow-up. In patients treated with sphincter conservation for anal carcinomas, long-term QOL as measured by the EORTC QLQ-C30 and QLQ-CR38 appears to be acceptable, with the exception of diarrhoea and perhaps sexual function. Moreover, the subset of patients who presented with severe complications and/or anal dysfunction showed poorer scores in most scales. © 1999 Cancer Research Campaign</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-dir>properties open_access</pmc-dir>
<pmc-comment> Original-type: ra</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id>
<journal-title>British Journal of Cancer</journal-title>
<issn pub-type="ppub">0007-0920</issn>
<issn pub-type="epub">1532-1827</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">10408404</article-id>
<article-id pub-id-type="pmc">2363100</article-id>
<article-id pub-id-type="pii">6690567</article-id>
<article-id pub-id-type="doi">10.1038/sj.bjc.6690567</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Regular Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Allal</surname>
<given-names>A S</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sprangers</surname>
<given-names>M A G</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Laurencet</surname>
<given-names>F</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reymond</surname>
<given-names>M A</given-names>
</name>
<xref ref-type="aff" rid="aff1">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kurtz</surname>
<given-names>J M</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
Division of Radiation Oncology and
<label>2</label>
Department of Surgery, University Hospital of Geneva, 1211 Geneva 14, Switzerland</aff>
<aff id="aff3">
<label>3</label>
Department of Medical Psychology, Academic Medical Center, 1105 Amsterdam, The Netherlands</aff>
<pub-date pub-type="ppub">
<month>07</month>
<year>1999</year>
</pub-date>
<volume>80</volume>
<issue>10</issue>
<fpage>1588</fpage>
<lpage>1594</lpage>
<history>
<date date-type="received">
<day>02</day>
<month>11</month>
<year>1998</year>
</date>
<date date-type="rev-recd">
<day>10</day>
<month>02</month>
<year>1999</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>02</month>
<year>1999</year>
</date>
</history>
<copyright-statement>Copyright 1999, Cancer Research Campaign</copyright-statement>
<copyright-year>1999</copyright-year>
<permissions>
<copyright-holder>Cancer Research Campaign</copyright-holder>
</permissions>
<abstract>
<p>This study was conducted to assess long-term Quality of Life (QOL) in patients treated by radiotherapy with or without chemotherapy for anal carcinomas. Patients with a maximum age of 80 years, and who were alive at least 3 years following completion of treatment with a functioning anal sphincter and without active disease, were selected for this study. Of 52 such patients identified, 41 (79%) were evaluable. There were 35 females and six males with a median age of 71 years (55–80). The median follow-up interval was 116 months (range 37–218). QOL was assessed using two self-rating questionnaires developed by the European Organization for Research and Treatment of Cancer: one for cancer-specific QOL (EORTC QLQ-C30) and one for site-specific QOL (EORTC QLQ-CR38). For the function scales a higher score represents a higher level of functioning (100 being the best score), whereas for the symptom scales a higher score indicates a higher level of symptomatology/problems (0 being the best score). For the QLQ-C30, the functional scale scores ranged from 71 (global quality of life) to 85 (role function) and the symptom scale scores from 6 (nausea-vomiting) to 28 (diarrhoea). For the QLQ-CR38 module the functional scale scores ranged from 13 (sexual functioning) to 74 (body image) and for the symptom scale scores from 5 (weight loss) to 66 (sexual dysfunction in males). None of the functional and symptom scale scores seemed to be better in patients with longer follow-up. In patients treated with sphincter conservation for anal carcinomas, long-term QOL as measured by the EORTC QLQ-C30 and QLQ-CR38 appears to be acceptable, with the exception of diarrhoea and perhaps sexual function. Moreover, the subset of patients who presented with severe complications and/or anal dysfunction showed poorer scores in most scales. © 1999 Cancer Research Campaign</p>
</abstract>
<kwd-group>
<kwd>anal carcinoma</kwd>
<kwd>quality of life</kwd>
<kwd>radiotherapy</kwd>
<kwd>chemotherapy</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Lorraine/explor/LrgpV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000000  | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000000  | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Lorraine
   |area=    LrgpV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     
   |texte=   
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Sat Nov 11 15:47:48 2017. Site generation: Wed Mar 6 23:31:34 2024